Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Sanda MG, Cadeddu JA, Kirkby E et al (2018) Clinically localized prostate cancer: AUA/ASTRO/SUO guideline. Part I: risk stratification, shared decision making, and care options. J Urol 199:683
2. Mottet N, Bellmunt J, Bolla M et al (2017) EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent. EurUrol 71:618
3. Auffenberg GB, Lane BR, Linsell S et al (2017) Practice- vs. physician-level variation in use of active surveillance for men with low-risk prostate cancer: implications for collaborative quality improvement. JAMA Surg 152:978
4. Luckenbaugh AN, Auffenberg GB, Hawken SR et al (2017) Variation in guideline concordant active surveillance followup in diverse urology practices. J Urol 197:621
5. Sayyid RK, Dingar D, Fleshner K et al (2017) What false-negative rates of non-invasive testing are active surveillance patients and uro-oncologists willing to accept in order to avoid prostate biopsy? Can UrolAssoc J 11:118
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献